Neoadjuvant Dual-Targeted HER2 Therapy and Neoadjuvant Chemo-Immunotherapy is Associated with Improved Nodal pCR and Reduced Axillary Surgery.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.